pyridoxine has been researched along with dihydroxyphenylalanine in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 70 (98.59) | 18.7374 |
1990's | 1 (1.41) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Watkins, CJ; Wiggins, JF; Wurtman, RJ | 1 |
Barbeau, A; Gonce, M | 1 |
Hunter, KR; Laurence, DR; Stern, GM | 1 |
Evered, DF | 1 |
Chase, TN; Ng, LK; Weiss, JL | 1 |
Hall, CD; Mozzis, CE; Prange, AJ; Weiss, EA | 1 |
Johnston, GA | 1 |
Tran, N | 1 |
Carter, AB | 2 |
Coquillat, G; Kurtz, D; Mack, G; Maitrot, D; Mandel, P; Micheletti, G; Rohmer, F; Warter, JM | 1 |
Kanig, K; Oesterle, W | 1 |
Matsuda, M; Wada, JA | 1 |
Hartmann-von Monakow, K | 1 |
Bird, MT; Paulson, GW | 1 |
Eichhorn, A; Schmutzler, F | 1 |
Puzyńska, L | 1 |
Diven, WF; Grever, MR; Meneely, RL; Neary, JT | 1 |
Bell, MA; Cotzias, GC; Düby, SE; Fehling, C; Papavasiliou, PS; Steck, AJ | 1 |
Cohen, G; Côté, L; Duvoisin, RC; Yahr, MD | 1 |
Colombini, CE; Henn, SW; McCoy, EE | 2 |
Pfeiffer, RF | 1 |
Sourkes, TL | 1 |
Foukas, MD | 1 |
Cassell, K; Shaw, K; Stern, G | 1 |
Lakke, JP; Meyer, R; Nienhuis, RJ; Schut, T; Zwols, F | 1 |
Hare, TA; Mackowiak, ED; Vogel, WH | 1 |
Kawahara, H; Kuzuya, F; Wakita, T | 2 |
Izumi, K; Kuroiwa, Y; Mawatari, S | 1 |
Barkhatova, VP; Gotovtseva, EV; Ivanova-Smolenskaia, IA; Markova, ED; Tkachev, RA | 1 |
Bianchine, JR; Hsu, TH; Messiha, FS; Preziosi, TJ | 1 |
Klawans, HL; Ringel, SP | 1 |
Davis, RL; Wolf, SM | 1 |
Cotzias, GC; Lawrence, WH; Papavasiliou, PS | 1 |
Mars, H | 2 |
Brown, FC; DeFoor, M | 1 |
Gehlen, W | 1 |
Fahn, S | 1 |
Simpson, AJ | 1 |
Ferel, D; Kaeser, HE; Wurmser, P | 1 |
Diemath, HE; Enge, S; Lechner, H | 1 |
Lipman, IJ | 1 |
Cotzias, GC; Düby, S; Ginos, J; Papavasiliou, PS; Steck, A | 1 |
Van Woert, MH | 1 |
Barrera, ER; Bennett, S; Mars, H | 1 |
Duvoisin, RC; Yahr, MD | 1 |
Ebadi, M; Pfeiffer, R | 1 |
Castaigne, P; Ribadeau-Dumas, JL; Rondot, P | 1 |
Klawans, HL | 1 |
Klawans, HL; Ringel, SP; Shenker, DM | 1 |
Cohen, G; Cote, LJ; Yahr, MD | 1 |
Abrams, WB; Coutinho, CB; Leon, AS; Spiegel, HE | 1 |
Abrams, WB; Leon, AS; Spiegel, HE; Thomas, G | 1 |
Coté, LD; Duvoisin, RC; Yahr, MD | 1 |
Cotzias, GC | 1 |
Calne, DB; French, TM; Spiers, AS | 1 |
Jameson, HD | 1 |
Golden, RL; Mortati, FS; Schroeter, GA | 1 |
Friedman, SA | 1 |
Bornstein, B; Eichhorn, F; Kott, E | 1 |
Cabot, EE | 1 |
Kuchel, O; Shigetomi, S | 1 |
DENYS, A; LEVY, J; MICHEL-BER, E | 1 |
11 review(s) available for pyridoxine and dihydroxyphenylalanine
Article | Year |
---|---|
[The current treatment of Parkinson's disease].
Topics: Amantadine; Antidepressive Agents, Tricyclic; Dihydroxyphenylalanine; Drug Combinations; Histamine Antagonists; Humans; Levodopa; Mental Disorders; Movement Disorders; Neurosecretory Systems; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Pyridoxine; Stereotaxic Techniques | 1976 |
[Biochemical treatment possibilities in psychoses].
Topics: Amino Acids; Ascorbic Acid; Dihydroxyphenylalanine; Humans; Methionine; Niacinamide; Nicotinic Acids; Phenylalanine; Psychotic Disorders; Pyridoxine; Schizophrenia; Tryptophan; Tyrosine | 1969 |
[Antiparkinson agents. 50].
Topics: Atropine; Dihydroxyphenylalanine; Diphenhydramine; Histamine H1 Antagonists; Humans; Mephenesin; Monoamine Oxidase Inhibitors; Nialamide; Parasympatholytics; Parkinson Disease; Phenothiazines; Propranolol; Pyridoxine; Scopolamine | 1970 |
Pyridoxine, DOPA, and Parkinsonism.
Topics: Administration, Oral; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Antagonism; Drug Interactions; Evaluation Studies as Topic; Humans; Parkinson Disease; Phenylacetates; Pyridoxal Phosphate; Pyridoxine; Vitamin B 6 Deficiency | 1972 |
The effect of neuropharmacological agents on metabolism of vitamin B 6 in brain.
Topics: 5-Hydroxytryptophan; Animals; Brain; Cannabis; Carbon Isotopes; Chromatography, Gel; Dihydroxyphenylalanine; Dopamine; Dronabinol; Ephedrine; Iproniazid; Liver; Melatonin; Mice; Norepinephrine; Phosphotransferases; Pyridoxal Phosphate; Pyridoxine; Rabbits; Reserpine; Semicarbazones; Serotonin | 1972 |
The effect of neuropharmacological agents on metabolism in vitamin B6 in brain.
Topics: 5-Hydroxytryptophan; Animals; Brain; Cannabis; Carbon Isotopes; Chromatography, Gel; Dihydroxyphenylalanine; Dopamine; Dronabinol; Ephedrine; Iproniazid; Liver; Melatonin; Mice; Norepinephrine; Phosphotransferases; Pyridoxal Phosphate; Pyridoxine; Rabbits; Reserpine; Semicarbazones; Serotonin | 1972 |
Comments on the adverse effect of concurrent pyridoxine administration on the efficacy of L-dopa in treating parkinsonism.
Topics: Dihydroxyphenylalanine; Drug Interactions; Humans; Models, Biological; Parkinson Disease; Pyridoxine | 1972 |
Influence of specific nutrients on catecholamine synthesis and metabolism.
Topics: Animals; Carbon Isotopes; Catecholamines; Copper; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Drug Interactions; Iron; Liver; Monoamine Oxidase; Pyridoxine; Rats; Riboflavin; Riboflavin Deficiency; Swine; Time Factors; Vitamin B 6 Deficiency | 1972 |
The carcinoid tumor, syndrome and spectrum. A review of the literature.
Topics: Antineoplastic Agents; Carcinoid Tumor; Cyproheptadine; Dihydroxyphenylalanine; Epinephrine; Ergolines; Humans; Hydroxyindoleacetic Acid; Mixed Function Oxygenases; Phenylalanine; Pyridoxine; Radiography; Serotonin; Serotonin Antagonists; Skin Tests; Tryptophan | 1969 |
L-dopa therapy in Parkinson's disease.
Topics: Delirium; Depression; Dihydroxyphenylalanine; Gastrointestinal Hemorrhage; Hallucinations; Humans; Hypotension, Orthostatic; Monoamine Oxidase; Movement Disorders; Nausea; Parkinson Disease; Phenothiazines; Plants, Medicinal; Psychotic Disorders; Pyridoxine; Rauwolfia; Tremor; Vomiting | 1971 |
Metabolic modification of Parkinson's disease and of chronic manganese poisoning.
Topics: Animals; Brain; Choline; Chronic Disease; Dihydroxyphenylalanine; Drug Synergism; Humans; Manganese Poisoning; Melatonin; Methionine; Monoamine Oxidase Inhibitors; Parkinson Disease; Phenylalanine; Poisoning; Pyridoxine; Tryptophan; Tyrosine | 1971 |
4 trial(s) available for pyridoxine and dihydroxyphenylalanine
Article | Year |
---|---|
[Pharmacological and biochemical approach to a syndrome of action and intention myoclonus in the course of degenerative disease of the nervous system].
Topics: 5-Hydroxytryptophan; Adult; Benzazepines; Cerebellar Ataxia; Clinical Trials as Topic; Diagnosis, Differential; Dibenzazepines; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Electroencephalography; Epilepsy; Friedreich Ataxia; Humans; Hydroxyindoleacetic Acid; Ketones; Male; Methyldopa; Methysergide; Myoclonus; Neurotransmitter Agents; Nitro Compounds; Pyridoxine; Serotonin; Synaptic Transmission; Tranquilizing Agents | 1973 |
Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
Topics: Administration, Oral; Adult; Biotransformation; Brain; Carbon Monoxide Poisoning; Cerebral Palsy; Child; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Humans; Hydrazines; Male; Methyldopa; Neurologic Examination; Neuromuscular Diseases; Parkinson Disease; Phenylacetates; Pyridoxine; Time Factors | 1972 |
Pyridoxine, DOPA, and Parkinsonism.
Topics: Administration, Oral; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Antagonism; Drug Interactions; Evaluation Studies as Topic; Humans; Parkinson Disease; Phenylacetates; Pyridoxal Phosphate; Pyridoxine; Vitamin B 6 Deficiency | 1972 |
An antilactogenic effect of pyridoxine.
Topics: Administration, Oral; Clinical Trials as Topic; Diethylstilbestrol; Dihydroxyphenylalanine; Dopamine; Female; Humans; Hypothalamus; Lactation; Neurons; Postpartum Period; Pregnancy; Prolactin; Pyridoxine; Time Factors | 1973 |
57 other study(ies) available for pyridoxine and dihydroxyphenylalanine
Article | Year |
---|---|
Carbidopa elevates hypothalamic dopa and serum prolactin in rats.
Topics: Animals; Brain Chemistry; Carbidopa; Dihydroxyphenylalanine; Hypothalamus; Male; Median Eminence; Postmortem Changes; Prolactin; Pyridoxine; Rats; Time Factors | 1979 |
Use of levodopa with other drugs.
Topics: Adult; Aged; Antidepressive Agents; Antiemetics; Digoxin; Dihydroxyphenylalanine; Diuretics; Drug Antagonism; Drug Synergism; Female; Guanethidine; Humans; Hypertension; Hypnotics and Sedatives; Hypoglycemic Agents; Hypotension; Male; Middle Aged; Nausea; Parkinson Disease; Pyridoxine; Time Factors | 1970 |
L-dopa. II.
Topics: Anorexia Nervosa; Cardiac Complexes, Premature; Dihydroxyphenylalanine; Drug Synergism; Humans; Hypotension, Orthostatic; Mental Disorders; Monoamine Oxidase Inhibitors; Movement Disorders; Nausea; Parkinson Disease; Pyridoxine; Tachycardia; Vomiting | 1970 |
L-dopa as a vitamin-B6 antagonist.
Topics: Amino Acids; Dihydroxyphenylalanine; Humans; Pyridoxine | 1971 |
Long-lasting dyskinesia induced by levodopa.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Injections; Injections, Intramuscular; Movement Disorders; Parkinson Disease; Pyridoxine; Time Factors | 1971 |
Inefficacy of tryptophan-pyridoxine in essential tremor.
Topics: Basal Ganglia; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Male; Parkinson Disease; Pyridoxine; Tremor; Tryptophan | 1971 |
L-dopa and vitamin B 6 .
Topics: Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Humans; Parkinson Disease; Pyridoxine | 1971 |
Levodopa.
Topics: Dihydroxyphenylalanine; Humans; Parkinson Disease; Phenylacetates; Pyridoxine; Time Factors | 1971 |
L-Dopa and pyridoxine.
Topics: Decarboxylation; Dihydroxyphenylalanine; Dopamine; Humans; Oxidation-Reduction; Parkinson Disease; Pyridoxal Phosphate; Pyridoxine | 1972 |
Letter: Pyridoxine contraindicated in parkinsonism.
Topics: Dihydroxyphenylalanine; Drug Antagonism; Humans; Metoclopramide; Nausea; Parkinson Disease; Pyridoxine | 1973 |
Letter: Pyridoxine in parkinsonism.
Topics: Dihydroxyphenylalanine; Drug Antagonism; Drug Interactions; Humans; Metoclopramide; Movement Disorders; Parkinson Disease; Promethazine; Pyridoxine | 1973 |
Learned escape behavior induced by brain electrical stimulation and various neuroactive agents.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Behavior, Animal; Cats; Dihydroxyphenylalanine; Drug Interactions; Electric Stimulation; Escape Reaction; Female; Fenclonine; Hypothalamus; Male; Mesencephalon; Methionine Sulfoximine; Methyltyrosines; Physostigmine; Pyridoxine; Reaction Time; Reserpine | 1971 |
[Specific therapy of extrapyramidal-motor syndromes].
Topics: Analgesics; Athetosis; Chorea; Datura stramonium; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; Extrapyramidal Tracts; Female; Humans; Huntington Disease; Methyldopa; Movement Disorders; Myoclonus; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Phenothiazines; Physical Therapy Modalities; Phytotherapy; Plants, Medicinal; Plants, Toxic; Pregnancy; Pyridoxine; Reserpine; Scopolamine; Stereotaxic Techniques; Tranquilizing Agents | 1969 |
The rigid form of Huntington's chorea.
Topics: Adult; Age Factors; Amantadine; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Movement Disorders; Pedigree; Pyridoxine; Sleep, REM; Spasm | 1971 |
Transamination of aromatic amino acids in rat liver and brain.
Topics: Amino Acids; Animals; Brain; Chromatography, Gel; Chromatography, Ion Exchange; Dihydroxyphenylalanine; Enzyme Activation; Hydrazines; Hydrogen-Ion Concentration; Kinetics; Liver; Male; Mitochondria, Liver; Phenylalanine; Protein Binding; Pyridoxal Phosphate; Pyridoxine; Rats; Spectrophotometry; Subcellular Fractions; Transaminases; Tryptophan; Tyrosine Transaminase; Ultraviolet Rays | 1972 |
The interactions between biogenic amines and pyridoxal, pyridoxal phosphate, and pyridoxal kinase.
Topics: 5-Hydroxytryptophan; Adenosine Triphosphate; Amines; Animals; Biogenic Amines; Brain; Cattle; Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Dopamine; Norepinephrine; Phosphotransferases; Picolines; Pyridoxal Phosphate; Pyridoxine; Serotonin; Spectrophotometry; Tryptophan; Tyrosine; Zinc | 1972 |
A computerised tracking technique for the assessment of Parkinsonian motor disabilities.
Topics: Adult; Aged; Diagnosis, Computer-Assisted; Dihydroxyphenylalanine; Disability Evaluation; Evaluation Studies as Topic; Female; Humans; Male; Methods; Middle Aged; Motor Skills; Movement; Parkinson Disease; Pyridoxine | 1973 |
[L-DOPA with the decarboxylase inhibitor Ro 4-4602 in the treatment of Parkinson's disease].
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Humans; Parkinson Disease; Pyridoxine | 1972 |
Measurement of aromatic L-amino acid decarboxylase--a technical comment.
Topics: Amino Acids; Animals; Brain; Carbon Dioxide; Carbon Isotopes; Carboxy-Lyases; Chloromercuribenzoates; Chromatography, Thin Layer; Decarboxylation; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Evaluation Studies as Topic; Liver; Mercaptoethanol; Pyridoxine; Rats; Stereoisomerism; Time Factors | 1972 |
[Symposium: metabolism in neurological disorders. 1. Parkinsonism. 1-(2). Dopamin metabolism in urine and brain of patients with parkinsonism, with special reference to vitamin B 6 and L-DOPA-treatment].
Topics: Animals; Brain; Dihydroxyphenylalanine; Dopamine; Humans; Male; Parkinson Disease; Pyridoxine; Rats | 1972 |
[L-dopa treatment and vitamin B 6 --clinical and chemical studies].
Topics: Aged; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease; Pyridoxine | 1972 |
Levodopa and related drugs.
Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Pyridoxine | 1973 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphenylalanine; Female; Hepatolenticular Degeneration; Humans; Hyperkinesis; Male; Pantothenate Kinase-Associated Neurodegeneration; Parkinson Disease; Penicillamine; Phenothiazines; Pyridoxine; Sulfhydryl Compounds; Trifluoperazine; Tropanes | 1973 |
Effect of pyridoxine on levodopa metabolism in normal and parkinsonian subjects.
Topics: Aged; Dihydroxyphenylalanine; Humans; Middle Aged; Parkinson Disease; Pharmaceutic Aids; Pyridoxine; Stimulation, Chemical | 1973 |
L-Dopa, B 6 , and alpha-methyldopa hydrazine.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease; Pyridoxine | 1973 |
Permanent dementia in idiopathic Parkinsonism treated with levodopa.
Topics: Aged; Amantadine; Brain; Dihydroxyphenylalanine; Electroencephalography; Humans; Male; Parkinson Disease; Psychoses, Substance-Induced; Pyridoxine; Trihexyphenidyl | 1973 |
Levodopa and dopamine in cerebrospinal fluid.
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Parkinson Disease; Pyridoxine; Spinal Puncture; Trihexyphenidyl | 1973 |
[Administration of L-dopa in Parkinson's syndrome and vitamin B6 metabolism].
Topics: Aged; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease; Pyridoxine | 1973 |
Letter: Pyridoxine and Parkinsonism.
Topics: Dihydroxyphenylalanine; Humans; Nausea; Parkinson Disease; Pyridoxine | 1973 |
Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
Topics: Brain; Carbidopa; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Homovanillic Acid; Humans; Hydrazines; Parkinson Disease; Pyridoxine | 1973 |
Trans-sulfuration in rat brain--effects of 3,4-dihydroxyphenylalanine (L-dopa).
Topics: Animals; Brain; Cystathionine; Dihydroxyphenylalanine; Kidney; Liver; Male; Nitro Compounds; Pyridoxine; Rats; S-Adenosylmethionine; Sulfur | 1974 |
Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions.
Topics: Carbidopa; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Drug Interactions; Drug Synergism; Homovanillic Acid; Humans; Hydrazines; Parkinson Disease; Pyridoxine | 1974 |
[Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].
Topics: Amantadine; Anesthetics; Anti-Bacterial Agents; Antidepressive Agents; Antihypertensive Agents; Antiparkinson Agents; Atropa belladonna; Depression; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypertension; Iatrogenic Disease; Parasympatholytics; Parkinson Disease; Plants, Medicinal; Plants, Toxic; Pyridoxine; Sympathomimetics; Tranquilizing Agents; Tropanes | 1974 |
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Injections, Intramuscular; Male; Methyldopa; Middle Aged; Movement Disorders; Parkinson Disease; Pyridoxine | 1974 |
[Treatment of Parkinson's syndrome with L-dopa].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antihypertensive Agents; Barbiturates; Dihydroxyphenylalanine; Dopamine; Drug Antagonism; Drug Incompatibility; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Hyperkinesis; Hypotension, Orthostatic; Male; Mental Disorders; Middle Aged; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Pyridoxine; Reserpine; Stereotaxic Techniques; Tranquilizing Agents | 1970 |
EEG depth leads during stereotaxic brain surgery. A report on 117 cases (5 target points, effects of 13 different drugs).
Topics: Amides; Amygdala; Antimetabolites; Asparagine; Benzoates; Brain; Brain Diseases; Cerebrovascular Circulation; Child; Chlordiazepoxide; Diazepam; Dihydroxyphenylalanine; Electroencephalography; Female; Fluphenazine; Gyrus Cinguli; Hippocampus; Humans; Hyperkinesis; Male; Methanol; Middle Aged; Parkinson Disease; Pyridines; Pyridoxine; Spasm; Stereotaxic Techniques; Thalamic Nuclei; Theophylline; Tranquilizing Agents; Triflupromazine; Vasodilator Agents | 1970 |
Low pyridoxine diet in parkinsonism.
Topics: Diet Therapy; Dihydroxyphenylalanine; Humans; Parkinson Disease; Pyridoxine; Vitamin B 6 Deficiency | 1972 |
Levadopa and pyridoxine.
Topics: Animals; Brain; Carboxy-Lyases; Decarboxylation; Dihydroxyphenylalanine; Drug Interactions; Humans; Hydrazines; Injections, Intraperitoneal; Methyldopa; Mice; Parkinson Disease; Propionates; Pyridoxine | 1972 |
Pyridoxine and levodopa in the treatment of Parkinsonism.
Topics: Dihydroxyphenylalanine; Humans; Parkinson Disease; Pyridoxine | 1972 |
On the mechanism of the nullification of CNS effects of L-DOPA by pyridoxine in Parkinsonian patients.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia; Benzyl Compounds; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Hydrazines; Male; Parkinson Disease; Pyridoxal Phosphate; Pyridoxine; Rats; Serine | 1972 |
[Medical treatment of Parkinson's disease].
Topics: Amantadine; Carboxy-Lyases; Dihydroxyphenylalanine; Humans; Parasympatholytics; Parkinson Disease; Phenothiazines; Pyridoxine; Reserpine | 1972 |
Effect of vitamin B 6 on levodopa-induced changes in spinal fluid homovanillic acid.
Topics: Dihydroxyphenylalanine; Dopamine; Female; Humans; Middle Aged; Parkinson Disease; Phenylacetates; Pyridoxine | 1971 |
Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Dopa Decarboxylase; Humans; Hydrazines; Middle Aged; Parkinson Disease; Pyridazines; Pyridoxine | 1971 |
The metabolism of orally administered L-dopa in Parkinson patients.
Topics: Dihydroxyphenylalanine; Dopamine; Epinephrine; Humans; Norepinephrine; Parkinson Disease; Phenylacetates; Pyridoxine | 1971 |
Absorption and metabolism of levodopa.
Topics: Animals; Decarboxylation; Dihydroxyphenylalanine; Dogs; Dopamine; Humans; Intestinal Absorption; Liver; Parkinson Disease; Phenylacetates; Pyridoxine | 1971 |
Pyridoxine antagonism of levodopa in parkinsonism.
Topics: Aged; Chromatography, Thin Layer; Decarboxylation; Dihydroxyphenylalanine; Dopamine; Female; Humans; Intestinal Absorption; Male; Middle Aged; Parkinson Disease; Phenylacetates; Pyridoxine; Stimulation, Chemical | 1971 |
Pyridoxine reversal of L-dopa effects in Parkinsonism.
Topics: Chorea; Dihydroxyphenylalanine; Humans; Parkinson Disease; Pyridoxine | 1969 |
Metabolic modification of some neurologic disorders.
Topics: Dihydroxyphenylalanine; Dopamine; Humans; Male; Manganese; Manganese Poisoning; Parkinson Disease; Poisoning; Pyridoxine | 1969 |
The effects of dopamine, L-dopa, L-tyrosine, and pyridoxine on sympathetic nerve endings in man.
Topics: Dihydroxyphenylalanine; Dopamine; Eye; Humans; Mydriatics; Nerve Endings; Pyridoxine; Sympathetic Nervous System; Tyrosine | 1970 |
Pyridoxine for levodopa-induced dystonia.
Topics: Dihydroxyphenylalanine; Humans; Male; Middle Aged; Muscular Diseases; Parkinson Disease; Pyridoxine; Torsion Abnormality | 1970 |
Levodopa, pyridoxine, and the burning feet syndrome.
Topics: Aged; Dihydroxyphenylalanine; Drug Antagonism; Foot Diseases; Humans; Male; Parkinson Disease; Pyridoxine; Vitamin B 6 Deficiency | 1970 |
Levodopa and pyridoxine-deficient states.
Topics: Dihydroxyphenylalanine; Humans; Parkinson Disease; Pyridoxine; Vitamin B 6 Deficiency | 1970 |
Excretion of dopa metabolites.
Topics: Dihydroxyphenylalanine; Dopamine; Humans; Parkinson Disease; Phenylacetates; Pyridoxine | 1971 |
[Vitamin tablets and patients with parkinsonism].
Topics: Dihydroxyphenylalanine; Humans; Parkinson Disease; Pyridoxine; Vitamins | 1971 |
Physician's advice needed in diets for Parkinsonism.
Topics: Diet; Dihydroxyphenylalanine; Food Service, Hospital; Humans; Parkinson Disease; Pyridoxine | 1971 |
Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
Topics: Adult; Cardiovascular System; Decarboxylation; Dihydroxyphenylalanine; Diuresis; Dopamine; Female; Hormones; Humans; Hydralazine; Hypertension; Kidney; Levodopa; Male; Middle Aged; Pyridoxine; Sodium | 1993 |
[Demonstration, by a pharmacological test, of relations between the metabolism of some pyridoxine derivatives and the antidepressive action, in the mouse, of monoamine oxidase inhibitor (IMAO)].
Topics: Animals; Antidepressive Agents; Dihydroxyphenylalanine; Mice; Monoamine Oxidase Inhibitors; Pyridoxal Phosphate; Pyridoxine | 1962 |